featured
Whiskey Company Scales Back Operations, Citing ‘Consumer Shifts’ Toward Marijuana As Alcohol Alternative
Published
8 hours agoon
A popular independent craft spirits distillery says it’s scaling back its operations—due in part to the fact that more adults are choosing marijuana over alcohol.
Heritage Distilling Company, Inc.–which has distillery locations for its whiskey and other spirits in Oregon and Washington State where cannabis is legal—said on Thursday that a confluence of factors informed its decision to close tasting rooms, shift to contract production partnerships and focus on direct-to-consumer sales.
The company listed four specific considerations that led to the consolidation of its operations. That includes “consumer shifts toward reduced alcohol consumption and alternative products, including marijuana.”
That shift is being closely monitored across the alcohol industry. Earlier this year, the CEO of Brown-Forman Corporation, which produces brands such as Jack Daniel’s and Woodford Reserve, said that the growing use of marijuana as an alternative to alcohol is putting “pressure” on the spirits industry.
This week, new congressional lobbying reports shows that many major companies such as Anheuser-Busch, Bacardi North America and Moet Hennessy USA are engaged in federal lobbying to influence cannabis policy amid the surge in interest into THC beverages.
“For more than a decade, Heritage Distilling tasting rooms were places for friends and family to gather to enjoy each other’s company and great spirits,” Jennifer Stiefel, president of Heritage Distilling, said in a press release on Thursday. “As we head into the final stretch of the year, we wanted to give our customers and club members two months of lead time to plan their final visits to our tasting rooms, to share in great memories and to thank the staff who helped them along their customer journey.”
The company also listed tax and regulatory challenges in Oregon and Washington State as additional reasons for the business model change.
The fact that evolving consumer preferences for cannabis factored into the decision isn’t entirely surprising, as there have been many recent market analyses and surveys indicating that marijuana legalization has proved to be a disruptive force for the alcohol industry.
A poll released earlier this month found that a majority of Americans believe marijuana represents a “healthier option” than alcohol—and most also expect cannabis to be legal in all 50 states within the next five years.
Another recent survey showed that four in five adults who drink cannabis-infused beverages say they’ve reduced their alcohol intake—and more than a fifth have quit drinking alcohol altogether.
That survey was released shortly after a leading alcohol industry group added a company that makes THC-infused drinks to its membership roster for the first time, furthering signaling the cultural shift.
This also comes at a time when younger Americans are increasingly using cannabis-infused beverages as a substitute for alcohol—with one in three millennials and Gen Z workers choosing THC drinks over booze for after-work activities like happy hours, according to a new poll of 1,000 young professionals.
This month it was revealed that the retail giant Target is soft launching sales of THC-infused beverages at select stores in Minnesota.
Meanwhile, Veterans of Foreign Wars (VFW) of the United States recently entered a first-of-its-kind partnership with a hemp THC beverage company, with a licensing branding deal that will support a variety of veterans services and promote cannabis drinks as a potential alcohol alternative with the drinks being available at VFW posts across the country.
Separately, while Target is apparently moving into the THC drink space, the airline Virgin Atlantic denied satirical and false claims earlier this year from a cannabis beverage company about a deal to sell its THC-infused beverages on flights.
Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
You may like
-
What To Know About Cannabis And A Brain Aneurysm
-
MariMed to Expand Brand Distribution to New York
-
Time for a Cannabis Reboot: Local Roots, Fair Markets, Real Change
-
Ohio Health Agency Grants $400,000 To Fund Psychedelics Education And Training For First Responders, Doctors And More
-
Curio Wellness Acquires 4 Greenlight Dispensaries in Missouri
-
The best places to be high in Seattle
featured
What To Know About Cannabis And A Brain Aneurysm
Published
16 minutes agoon
October 23, 2025
Discover what to know about cannabis and a brain aneurysm—risks, recovery, and medical cautions.
When celebrity Kim Kardashian recently revealed she was diagnosed with a small brain aneurysm—reportedly detected during a routine MRI and attributed by her doctors to stress—her disclosure sparked interest in a condition most people don’t know much about. A brain aneurysm is a bulging or ballooning blood vessel in the brain, which can be life-threatening if it ruptures. With growing interest around cannabis use—both medically and recreationally—it’s worth exploring what to know about cannabis and a brain aneurysm.
RELATED: The Science Behind Cannabis And Happiness
A brain aneurysm (sometimes called an intracranial aneurysm) occurs when a weakened area of a blood vessel in the brain bulges outward. If the aneurysm ruptures, it can lead to a major bleed called a subarachnoid hemorrhage—a medical emergency. Many aneurysms remain small and never rupture, but risk factors include high blood pressure, smoking, genetic predisposition, and possibly vascular stress. Kim Kardashian’s case underlines how even individuals with public profiles and access to healthcare can face this silent risk.

Cannabis—or more precisely its components such as cannabidiol (CBD) and tetrahydrocannabinol (THC)—has been studied for a variety of health issues. For some conditions like chronic pain, certain forms of epilepsy, or spasticity in multiple sclerosis, cannabinoids may offer symptomatic relief. There is emerging evidence medical marijuana can improve quality of life for some patients: reducing pain, improving sleep or mood, and even decreasing reliance on opioids in certain contexts.
In the broad sense, in jurisdictions across the U.S., many patients use it under medical supervision for conditions like migraine, nausea from chemotherapy, or chronic neuropathic pain. “Medical” use does not equate to “safe in all contexts”—especially when other serious medical issues are present.
When it comes to brain aneurysms—particularly after diagnosis or treatment—the research raises caution flags about cannabis use:
- Studies show people who have had an aneurysmal subarachnoid hemorrhage (a burst aneurysm), cannabis users had higher rates of delayed cerebral ischemia (DCI)—a serious complication which can lead to poor outcome. One large study found cannabis users had about a 2.7 times greater risk of DCI compared with non-users.
- Other studies link recreational cannabis use to a higher likelihood of having an aneurysm rupture in the first place—one estimate suggested about an 18 % increased risk.
- Research also suggests cannabis affects vascular tone, cerebral blood flow, mitochondrial function in brain cells, and may contribute to vasospasm (narrowing of blood vessels) or oxidative stress—mechanisms which are particularly concerning in someone with a vulnerable blood vessel wall.
- One review warned even for unruptured aneurysms, if cannabis is used, individuals should be aware they may face worse outcomes should rupture occur.
RELATED: Evidence About Burning Mouth Syndrome And Cannabinoids
If you or someone you know has been diagnosed with a brain aneurysm (ruptured or unruptured), here are some practical steps:
- Talk to your neurologist/neurosurgeon about cannabis use. The research suggests elevated risks in people with aneurysms who use cannabis.
- Avoid assuming “medical use = safe.” Even if you’re using cannabis under a physician’s care, an aneurysm changes the risk profile.
- Focus on established risk-reduction: control blood pressure, stop smoking, manage cholesterol, avoid stimulants. These traditional strategies remain foundational.
- If you have an untreated aneurysm and are considering cannabis for medical reasons, proceed with caution.Ask your medical team about the specific size, location, treatment plan of your aneurysm and whether there are recommended restrictions.
- After an aneurysm rupture or treatment, strongly consider abstaining or closely monitoring any cannabis use. The data indicate increased complication rates in this particular setting.
The public disclosure by Kim Kardashian highlights how common aneurysms may be, but it also reminds us the decision to use cannabis in a medical context should be made carefully. While cannabis offers genuine medical benefits for some conditions, when a brain aneurysm is in the picture—especially one which has ruptured or is being observed—caution is warranted. Speak with a neurologist familiar with cerebrovascular risk, weigh the benefits and the unique risks, and make an informed choice rather than assuming “legal = safe.”
Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
[PRESS RELEASE] – NORWOOD, Mass., Oct. 23, 2025 – MariMed Inc., a leading cannabis consumer packaged goods company and retailer, announced a licensing agreement with Farm 2 Hand LLC, a New York State cannabis license holder, that will introduce the company’s top-selling portfolio of products throughout New York State. Terms of the agreement were not disclosed.
Farm 2 Hand intends to manufacture and distribute a variety of MariMed’s edible products as permitted under New York regulations. Those are initially expected to include Betty’s Eddies fruit chews; Bubby’s Baked baked goods; and InHouse gummies. The products will be produced in a new kitchen that MariMed will design and equip for Farm 2 Hand at Farm 2 Hand’s Bronx production facility.
“Expanding the availability of our brands to the Empire State and its $6 billion total addressable market marks a significant step forward in our plan to own top-selling cannabis brands across the U.S.,” MariMed CEO Jon Levine said. “The addition of New York to our distribution footprint will help drive wholesale revenue, and being in the nation’s top media and influencer market will also help increase national awareness for our brands.”
The company expects its products will be available to New York’s 500-plus dispensaries in 2026, following the build-out of the kitchen and regulatory approval.
Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
featured
Time for a Cannabis Reboot: Local Roots, Fair Markets, Real Change
Published
2 hours agoon
October 23, 2025
Written by Shaleen Title and Damian Fagon
Federal cannabis bills are not coming to save us. It’s October 2025, and the corporate-led strategy that has dominated the movement is dead. The same bills get introduced over and over, and like zombies, we deliver the same recycled responses, fight the same identical fights, and make no progress. We are no closer to federal legalization than we were five years ago. The attempted corporate takeover has clearly failed, and we’re still pretending that doing the exact same thing will yield a different result.
The cannabis policy movement needs a reboot. We are ready to pull the plug on this failed approach and start building the cannabis market we actually want instead, and we hope you will join us. It’s time for a complete overhaul, with a new strategy that puts local communities and fair markets at the center.
Wall Street Weed still frames this as a fairy tale in which they are the heroes, fighting valiantly for incremental wins while moral purists hold them back. But the truth is simpler: no one is holding them back. Despite all the money and lobbying, their strategy has failed.
The movement tried selling out to publicly traded cannabis companies – the most ambitious among us even selling out to Big Tobacco – and we remain stalled. Their lobbyists promised momentum and results but delivered nothing. None of their preferred bills passed, and none of their stated goals were met.
The good news is that we can change course by putting people over profits and building local power to bring real change. But first, we have to name the zombie ideas that keep staggering through every legislative session, devouring resources and delivering nothing.
First: “Federal legalization now; we’ll work out the details later.”
That argument made sense when we didn’t yet know what legalization looked like. But we do now. The details are the policy. Most people in the U.S. have access to dispensaries. They don’t particularly care about banking access and tax rates. Instead, we need to tell a clear story supporting a specific federal cannabis package with guardrails that protect all of us – consumers, workers, small businesses, and yes, communities harmed by prohibition.
Thanks to the selfless people who began this movement, the reform of federal cannabis laws remains a massively popular issue across the political spectrum. Our research shows that a majority of Americans believe legalization should benefit people who use marijuana as medicine, people who use marijuana for pleasure, people who have been harmed by past enforcement, workers, everyday people, locally owned businesses, and small businesses. A majority does not say the same for pharma, alcohol, tobacco, or large corporations. It’s time to start working toward that goal.
Second: “The market will figure it out”
This is not the 1980s. Relying on the so-called “free market” to equitably distribute value back to workers, small businesses, and consumers is a joke, and we all know it. Markets are intentionally constructed through policy and politics, not magic. Corporate free-for-alls don’t distribute wealth fairly; they concentrate it at the top. We can have markets that reward labor and local small businesses, but only if we build them intentionally.
That means structuring markets that separate growing, processing, and retail operations so no company can dominate every stage of the supply chain. It means explicitly limiting ownership concentration, protecting local programs that favor local businesses, and creating real protections for workers. We already have a blueprint from states that have created relatively fair and competitive cannabis markets, far more friendly to small businesses than comparable industries. These aren’t accidents – they’re the result of intentional policy design, and they can be replicated at the federal level.
Third: “Any marijuana bill is better than no marijuana bill”
No, it isn’t. Marijuana bills are not universally good. It will take an adjustment, but our movement has to understand and accept that some bills would have genuinely harmful consequences. In our view, a federal legalization bill that hands control of the market to giant conglomerates and continues criminalization in the American South is worse than the status quo. Passing the wrong bill could cement monopoly power for a generation.
And look, this would be a fair debate if corporate-backed bills were actually passing. But they’re not. So why are we tirelessly supporting their failed bills with our limited time, energy, and resources every session? Do you really think they’ll remember and reward us if they ever get their tax cut or buyout?
Let’s have some self-respect. Any bill without a plan to prevent monopolization should be a nonstarter. Let’s stop conflating justice with profits. Let’s stop pretending that incremental “progress” that only benefits large corporations is progress at all. Because states really are making some progress – they are clearing convictions, funding equity programs, and giving new entrepreneurs a shot. We need federal policy that protects and enhances these efforts, not erases them.
Looking Forward
For those of us who’ve been in this fight since before 2012, it’s time for clear-eyed assessment. We helped pass and implement one of the most significant policy changes in modern U.S. history, and that’s worth celebrating. But the playbook we built belonged to a different era, a time when wealth was less concentrated and corporate responsibility still meant something. Today’s inequality demands new tools. The old libertarian formula doesn’t just fail; it fuels the very harms we set out to repair.
The next phase belongs to a multicultural movement that understands post-legalization realities and sees how monopolies and regulatory capture threaten both justice and opportunity. Those of us who shaped the early reforms can still play a role as mentors helping this new generation take cannabis policy where it needs to go.
This new generation already has its north star: people first, profit last. As Kassandra Frederique of the Drug Policy Alliance reminds us, “The drug can’t have more rights than the people do.” That principle is not rhetorical; it’s the heart of this fight. If we are still obsessing over banking access and tax deductions while consumers are being criminalized again, we no longer have a movement. Brownie Mary and the AIDS activists who built this fight understood that cannabis was always about the health, safety and dignity of people.
And the people are still with us. Seventy percent of Americans support some form of legalization, but they are not asking for more corporate consolidation or Wall Street control. The cannabis industry doesn’t have to become yet another monopoly that drains more than it provides. But changing that outcome means replacing the old rules with new ones built around fairness, transparency, and justice.
The next era of cannabis reform will not be decided in Congress or corporate boardrooms. It will be built, once again, by people.
Shaleen Title and Damian Fagon are former cannabis regulators with Parabola Center for Law and Policy. Register for Parabola Center’s annual People Over Profits event in NYC this Saturday at parabolacenter.com/crashcourse.
This article is from an external, unpaid contributor. It does not represent High Times’ reporting and has not been edited for content or accuracy.
Author: mscannabiz.com
MScannaBIZ for all you Mississippi Cannabis News and Information.
What To Know About Cannabis And A Brain Aneurysm
MariMed to Expand Brand Distribution to New York
Time for a Cannabis Reboot: Local Roots, Fair Markets, Real Change
Ohio Health Agency Grants $400,000 To Fund Psychedelics Education And Training For First Responders, Doctors And More
Curio Wellness Acquires 4 Greenlight Dispensaries in Missouri
The best places to be high in Seattle
Colombia’s Bold Offer to Trump: Legal Weed Exports for Peace
Trump DOJ Asks Supreme Court For Delayed Schedule In Case On Marijuana Users’ Gun Rights
Whiskey Company Scales Back Operations, Citing ‘Consumer Shifts’ Toward Marijuana As Alcohol Alternative
Smart Cannabis: The AI Revolution No Operator Can Ignore
New Jersey Gubernatorial Candidates Need To Step Up For Cannabis Consumers (Op-Ed)
Millennials Are Spending Big on Luxury Travel
West Virginia Medical Marijuana Revenue Is Supposed To Support Drug Treatment Programs, But Sits Unspent As Officials Worry About Federal Prohibition
Frequent Marijuana Use Is Tied To Lower Risk Of Liver Disease From Alcohol, New Study Finds
Ohio bill to scale back cannabis legalization passed by House (Newsletter: October 23, 2025)
FDA Weighs Petition On ‘Significant Harm’ Of Marijuana Hair Testing Device’s Positive Results From Secondhand Smoke
Wisconsin Lawmakers Rally for Medical Cannabis Legalization in Committee Hearing
Massachusetts Campaign To Roll Back Marijuana Legalization Law Is ‘On Track’ To Make 2026 Ballot, Spokesperson Says
Village Farms Introduces Industry-First, One-Way Aroma Valve in Cannabis Packaging
Ohio House Passes Bill To Remove Voter-Approved Marijuana Legalization Protections And Restrict Hemp Market
Sorting Robotics Becomes Cannabis Manufacturing’s First True Systems Integrator
Wisconsin Senators Hold Hearing On GOP Leader’s New Medical Marijuana Legalization Bill
Tariffs And Visas Add To The Cannabis Industry’s Misery
Rhode Island Cannabis Chair Steps Down; Adult-Use Dispensary Awards Months Away
Alert: Department of Cannabis Control updates data dashboards with full data for 2023
Connecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!
5 best CBD creams of 2024 by Leafly
Recreational cannabis on ballot for third time in South Dakota
EU initiative begins bid to open access to psychedelic therapies
New Study Analyzes the Effects of THCV, CBD on Weight Loss
Free delta-9 gummies from Bay Smokes
5 best autoflower seed banks of 2024 by Leafly
Discover New York’s dankest cannabis brands [September 2024]
May 2024 Leafly HighLight: Pink Runtz strain
Press Release: CANNRA Calls for Farm Bill to Clarify Existing State Authority to Regulate Hemp Products
5 best THC drinks of 2024 by Leafly
Local medical cannabis dispensary reacts to MSDH pulling Rapid Analytics License – WLBT
6 best CBD gummies of 2024 by Leafly
Curaleaf Start Process Of Getting Their Claws Into The UK’s National Health System – With Former MP (Resigned Today 30/5/24) As The Front Man
Horn Lake denies cannabis dispensary request to allow sale of drug paraphernalia and Sunday sales | News
5 best delta-9 THC gummies of 2024 by Leafly
The Daily Hit: October 2, 2024
Mississippi city official pleads guilty to selling fake CBD products
Nevada CCB to Accept Applications for Cannabis Establishments in White Pine County – “Only one cultivation and one production license will be awarded in White Pine County”
5 best THCA flower of 2024 by Leafly
Weekly Update: Monday, May 13, 2024 including, New Guide for Renewals & May Board meeting application deadline
6 best hemp pre-rolls of 2024 by Leafly
PRESS RELEASE : Justice Department Submits Proposed Regulation to Reschedule Marijuana
Trending
-
California Cannabis Updates1 year agoAlert: Department of Cannabis Control updates data dashboards with full data for 2023
-
Breaking News1 year agoConnecticut Appoints The US’s First Cannabis Ombudsperson – Yes there is a pun in there and I’m Sure Erin Kirk Is Going To Hear It More Than Once!
-
best list1 year ago5 best CBD creams of 2024 by Leafly
-
Business1 year agoRecreational cannabis on ballot for third time in South Dakota
-
Business1 year agoEU initiative begins bid to open access to psychedelic therapies
-
cbd1 year agoNew Study Analyzes the Effects of THCV, CBD on Weight Loss
-
Bay Smokes1 year agoFree delta-9 gummies from Bay Smokes
-
autoflower seeds1 year ago5 best autoflower seed banks of 2024 by Leafly


